Compare, Analyse Cadila Healthcare with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ACTAVIS (US) - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   ACTAVIS
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-19
ACTAVIS
Dec-18
CADILA HEALTHCARE/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs43214,478-   
Low Rs3069,712-   
Sales per share (Unadj.) Rs128.63,551.4-  
Earnings per share (Unadj.) Rs18.5-1,143.9-  
Cash flow per share (Unadj.) Rs24.4374.2-  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs101.514,647.7-  
Shares outstanding (eoy) m1,023.74332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.93.4 84.3%   
Avg P/E ratio x19.9-10.6 -188.4%  
P/CF ratio (eoy) x15.132.3 46.9%  
Price / Book Value ratio x3.60.8 441.0%  
Dividend payout %18.90-   
Avg Mkt Cap Rs m378,1704,022,682 9.4%   
No. of employees `00012.416.9 73.6%   
Total wages/salary Rs m21,2410-   
Avg. sales/employee Rs Th10,585.069,892.5 15.1%   
Avg. wages/employee Rs Th1,707.80-   
Avg. net profit/employee Rs Th1,526.5-22,512.4 -6.8%   
INCOME DATA
Net Sales Rs m131,6561,181,183 11.1%  
Other income Rs m2,01122,588 8.9%   
Total revenues Rs m133,6671,203,771 11.1%   
Gross profit Rs m29,73130,953 96.1%  
Depreciation Rs m5,986504,930 1.2%   
Interest Rs m1,93568,161 2.8%   
Profit before tax Rs m23,821-519,550 -4.6%   
Minority Interest Rs m4690-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0132,506 0.0%   
Tax Rs m5,303-6,584 -80.5%   
Profit after tax Rs m18,987-380,460 -5.0%  
Gross profit margin %22.62.6 861.8%  
Effective tax rate %22.31.3 1,756.7%   
Net profit margin %14.4-32.2 -44.8%  
BALANCE SHEET DATA
Current assets Rs m84,981484,460 17.5%   
Current liabilities Rs m73,425428,569 17.1%   
Net working cap to sales %8.84.7 185.5%  
Current ratio x1.21.1 102.4%  
Inventory Days Days7520 380.5%  
Debtors Days Days11066 165.2%  
Net fixed assets Rs m133,493133,703 99.8%   
Share capital Rs m1,0240-   
"Free" reserves Rs m102,8390-   
Net worth Rs m103,8634,871,829 2.1%   
Long term debt Rs m39,4971,715,548 2.3%   
Total assets Rs m234,8317,615,778 3.1%  
Interest coverage x13.3-6.6 -201.0%   
Debt to equity ratio x0.40.4 108.0%  
Sales to assets ratio x0.60.2 361.5%   
Return on assets %8.9-4.1 -217.3%  
Return on equity %18.3-7.8 -234.1%  
Return on capital %18.3-4.8 -377.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m36,8110-   
CASH FLOW
From Operations Rs m28,823421,992 6.8%  
From Investments Rs m-57,387231,830 -24.8%  
From Financial Activity Rs m18,846-724,265 -2.6%  
Net Cashflow Rs m-7,105-70,091 10.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 74.82 Rs / USD

Compare CADILA HEALTHCARE With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: J.B.CHEMICALS  ELDER PHARMA  ALEMBIC PHARMA  GSK PHARMA  NOVARTIS  



Today's Market

Sensex Ends 362 Points Higher on RBI Loan Recast; IT and FMCG Stocks Rally(Closing)

Indian share markets ended on a positive note today after the RBI kept the repo rate unchanged at 4%.

Related Views On News

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio (Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock (Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Gold or Silver: Which One Should You Buy Now? (Fast Profits Daily)

Jul 24, 2020

Silver and gold are both vying for your attention. Which is the better trade today?

A Zero Loss Strategy that Also Maximizes Returns in Volatile Stock Markets Views On News (Views On News)

Jul 24, 2020

Here's how to never lose money in stock markets.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2020
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

CADILA HEALTHCARE SHARE PRICE


Aug 6, 2020 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

FEATURED VIDEOS

Can You Win a Stock Market Championship Using My Penny Stock Strategy? Let's Find Out

How to Use Price Action to Find High Conviction Trading Ideas

Why This Attractive 'Silver' Stock With 9% Dividends Is Not a Buy

A Zero Loss Strategy that Also Maximizes Returns in Volatile Stock Markets

More Featured Videos

MARKET STATS